Abstract
Treatment of multidrug-resistant Mycobacterium tuberculosis is a challenge. This letter describes the emergence of resistance to new therapies, bedaquiline and delamanid.
Navigation auf zora.uzh.ch
Bloemberg, Guido V; Keller, Peter M; Stucki, David; Trauner, Andrej; Borrell, Sonia; Latshang, Tsogyal; Coscolla, Mireia; Rothe, Thomas; Hömke, Rico; Ritter, Claudia; Feldmann, Julia; Schulthess, Bettina; Gagneux, Sebastien; Böttger, Erik C (2015). Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis. New England Journal of Medicine, 373(20):1986-1988.
Treatment of multidrug-resistant Mycobacterium tuberculosis is a challenge. This letter describes the emergence of resistance to new therapies, bedaquiline and delamanid.
Item Type: | Journal Article, refereed, original work |
---|---|
Communities & Collections: | 04 Faculty of Medicine > Institute of Medical Microbiology |
Dewey Decimal Classification: | 570 Life sciences; biology
610 Medicine & health |
Scopus Subject Areas: | Health Sciences > General Medicine |
Language: | English |
Date: | 12 November 2015 |
Deposited On: | 17 Dec 2015 11:20 |
Last Modified: | 14 Sep 2024 01:36 |
Publisher: | Massachusetts Medical Society |
ISSN: | 0028-4793 |
OA Status: | Green |
Free access at: | PubMed ID. An embargo period may apply. |
Publisher DOI: | https://doi.org/10.1056/NEJMc1505196 |
PubMed ID: | 26559594 |